| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83257-026-11 | 83257-026 | HUMAN PRESCRIPTION DRUG | YESINTEK | ustekinumab | SOLUTION | INTRAVENOUS | 20250222 | N/A | BLA | BLA761406 | Biocon Biologics Inc. | USTEKINUMAB | 130 mg/26mL | 1 VIAL, SINGLE-USE in 1 BOX (83257-026-11) / 26 mL in 1 VIAL, SINGLE-USE |
| 83257-025-41 | 83257-025 | HUMAN PRESCRIPTION DRUG | YESINTEK | ustekinumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20250222 | N/A | BLA | BLA761406 | Biocon Biologics Inc. | USTEKINUMAB | 90 mg/mL | 1 SYRINGE in 1 CARTON (83257-025-41) / 1 mL in 1 SYRINGE |
| 83257-023-41 | 83257-023 | HUMAN PRESCRIPTION DRUG | YESINTEK | ustekinumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20250222 | N/A | BLA | BLA761406 | Biocon Biologics Inc. | USTEKINUMAB | 45 mg/.5mL | 1 SYRINGE in 1 CARTON (83257-023-41) / .5 mL in 1 SYRINGE |
| 83257-024-11 | 83257-024 | HUMAN PRESCRIPTION DRUG | YESINTEK | ustekinumab | INJECTION, SOLUTION | SUBCUTANEOUS | 20250222 | N/A | BLA | BLA761406 | Biocon Biologics Inc. | USTEKINUMAB | 45 mg/.5mL | 1 VIAL, SINGLE-USE in 1 CARTON (83257-024-11) / .5 mL in 1 VIAL, SINGLE-USE |